Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proto-oncogene tyrosine-protein kinase Fyn (Fyn) is a non-receptor tyrosine kinase belonging to the Src family. It plays crucial roles in cell growth, survival, adhesion, cytoskeletal organization, and signal transduction pathways, particularly in immune cells and neurons. Fyn dysregulation is implicated in various diseases, including cancer and neurological disorders, making it a potential therapeutic target.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene tyrosine-protein kinase Fyn (FYN).